1. Home
  2. LRMR vs MNMD Comparison

LRMR vs MNMD Comparison

Compare LRMR & MNMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LRMR
  • MNMD
  • Stock Information
  • Founded
  • LRMR N/A
  • MNMD 2019
  • Country
  • LRMR United States
  • MNMD United States
  • Employees
  • LRMR N/A
  • MNMD N/A
  • Industry
  • LRMR Biotechnology: Pharmaceutical Preparations
  • MNMD Pharmaceuticals and Biotechnology
  • Sector
  • LRMR Health Care
  • MNMD Health Care
  • Exchange
  • LRMR Nasdaq
  • MNMD Nasdaq
  • Market Cap
  • LRMR 426.9M
  • MNMD 485.5M
  • IPO Year
  • LRMR N/A
  • MNMD N/A
  • Fundamental
  • Price
  • LRMR $4.02
  • MNMD $7.97
  • Analyst Decision
  • LRMR Strong Buy
  • MNMD Strong Buy
  • Analyst Count
  • LRMR 8
  • MNMD 9
  • Target Price
  • LRMR $19.63
  • MNMD $28.75
  • AVG Volume (30 Days)
  • LRMR 1.0M
  • MNMD 1.1M
  • Earning Date
  • LRMR 10-30-2024
  • MNMD 11-07-2024
  • Dividend Yield
  • LRMR N/A
  • MNMD N/A
  • EPS Growth
  • LRMR N/A
  • MNMD N/A
  • EPS
  • LRMR N/A
  • MNMD N/A
  • Revenue
  • LRMR N/A
  • MNMD N/A
  • Revenue This Year
  • LRMR N/A
  • MNMD N/A
  • Revenue Next Year
  • LRMR N/A
  • MNMD N/A
  • P/E Ratio
  • LRMR N/A
  • MNMD N/A
  • Revenue Growth
  • LRMR N/A
  • MNMD N/A
  • 52 Week Low
  • LRMR $3.01
  • MNMD $3.35
  • 52 Week High
  • LRMR $13.68
  • MNMD $12.22
  • Technical
  • Relative Strength Index (RSI)
  • LRMR 26.41
  • MNMD 56.42
  • Support Level
  • LRMR $3.01
  • MNMD $6.89
  • Resistance Level
  • LRMR $6.91
  • MNMD $7.58
  • Average True Range (ATR)
  • LRMR 0.55
  • MNMD 0.46
  • MACD
  • LRMR -0.19
  • MNMD -0.03
  • Stochastic Oscillator
  • LRMR 31.28
  • MNMD 55.25

About LRMR Larimar Therapeutics Inc.

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using novel cell-penetrating peptide technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.

About MNMD Mind Medicine (MindMed) Inc.

Mind Medicine Inc is a biopharmaceutical company. The company produces to treat brain health disorders. The company discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of treatments based on psychedelic substances. The firm is having an approach towards developing the next generation of psychedelic-inspired medicines and therapies.

Share on Social Networks: